The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
The evolution of MDM2 family genes
Abstract
MDM2 and MDM4 are proto-oncoproteins that bind to and inhibit members of the p53 protein family, p53, p73 and possibly p63. p53 is a mammalian tumor suppressor and p63 and p73 are critical for development. With the sequencing of genomes from multiple organisms there is mounting evidence for a consensus scenario of p53 gene family evolution. A single p53/p63/p73 gene is in invertebrates and required for maintenance of germline DNA. Gene duplication occurred in an ancestor in common with cartilaginous fishes, giving rise to a separate p53 gene and at least one ancestral p63/p73 gene. In bony vertebrates, all three p53 gene family paralogs, p53, p63, and p73 are distinct genes. This raises the question of how MDM2 and MDM4 genes evolved. We show evidence that MDM2 and MDM4 arose from a gene duplication event prior to the emergence of bony vertebrates more than 440 million years ago. Comparative genome studies indicate that invertebrate organisms have only one MDM homolog. In jawed vertebrates, the p53-binding domains of MDM2 and MDM4 proteins evolved at a high rate, approaching the evolution rate of the MDM2-binding domain of p53. However, the MDM2-binding domain of p73 exhibits markedly stronger conservation suggesting novel p53-independent functions. The most conserved domain within all MDM2 family members is the RING domain of the MDM2 ortholog which is responsible for ubiquitination of p53 and heterodimerization with MDM4. We suggest a model where dimerization is an ancient function of MDM and ubiquitination activity was acquired later near the MDM gene duplication event coinciding with the time of the emergence of p53 as a distinct gene.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A gene duplication shortly before the radiation of vertebrates then led to two distinct MDM-family proteins being present in all vertebrates: MDM2 and MDMX, with the latter lacking E3 ligase activity [24, 66].”
From Evolutionary history of the p53 family DNA-binding domain: insights from an Alvinella pompejana homolog (2022) · cites this paper as [66]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain
Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951
Amplification of a gene encoding a p53-associated protein in human sarcomas
Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., & Vogelstein, B. (1992) · Nature · doi:10.1038/358080a0 · Cited by 1,949
Regulating the p53 pathway: in vitro hypotheses, in vivo veritas
Toledo, F., & Wahl, G. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc2012 · Cited by 1,286
The genome of the choanoflagellate Monosiga brevicollis and the origin of metazoans
King, N., Westbrook, M. J., Young, S. L., Kuo, A., Abedin, M., Chapman, J., Fairclough, S., Hellsten, U., Isogai, Y., Letunic, I., et al. (2008) · Nature · doi:10.1038/nature06617 · Cited by 1,139
Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2
Li, M., Brooks, C. L., Wu-Baer, F., Chen, D., Baer, R., & Gu, W. (2003) · Science · doi:10.1126/science.1091362 · Cited by 804
MDMX: a novel p53‐binding protein with some functional properties of MDM2.
Shvarts, A., Steegenga, W. T., Riteco, N., van Laar, T., Dekker, P., Bazuine, M., van Ham, R. C., van der Houven van Oordt, W., Hateboer, G., van der Eb, A. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00919.x · Cited by 648
The p53 orchestra: Mdm2 and Mdmx set the tone
Wade, M., Wang, Y. V., & Wahl, G. M. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.01.009 · Cited by 450
HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53
Linares, L. K., Hengstermann, A., Ciechanover, A., Müller, S., & Scheffner, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2030930100 · Cited by 361
MDM2 suppresses p73 function without promoting p73 degradation
Zeng, X., Chen, L., Jost, C. A., Maya, R., Keller, D., Wang, X., Kaelin, W. G., Oren, M., Chen, J., & Lu, H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3257 · Cited by 334
Linke, K., Mace, P. D., Smith, C. A., Vaux, D. L., Silke, J., & Day, C. L. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402309 · Cited by 288
MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner
Bond, G. L., Hirshfield, K. M., Kirchhoff, T., Alexe, G., Bond, E. E., Robins, H., Bartel, F., Taubert, H., Wuerl, P., Hait, W., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0180 · Cited by 287
TGF-β1–induced expression of human Mdm2 correlates with late-stage metastatic breast cancer
Araki, S., Eitel, J. A., Batuello, C. N., Bijangi-Vishehsaraei, K., Xie, X.-J., Danielpour, D., Pollok, K. E., Boothman, D. A., & Mayo, L. D. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39194 · Cited by 133
Solution structure of the Hdm2 C2H2C4 RING, a domain critical for ubiquitination of p53
Kostic, M., Matt, T., Martinez-Yamout, M. A., Dyson, H. J., & Wright, P. E. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.08.027 · Cited by 128 · cited 1×
“The RING domain is also necessary for MDM2 homo-oligomerization and for heterodimerization with MDM4 (Kostic et al., 2006; Linke et al., 2008).”
MDM2 and MDMX can interact differently with ARF and members of the p53 family
Wang, X., Arooz, T., Siu, W. Y., Chiu, C. H. S., Lau, A., Yamashita, K., & Poon, R. Y. C. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02124-x · Cited by 94
MdmX binding to ARF affects Mdm2 protein stability and p53 transactivation
Jackson, M. W., Lindström, M. S., & Berberich, S. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010685200 · Cited by 74
Research works printed but not linked: 52
- Altschul, 1997, Gapped BLAST and PSI-BLAST: a new generation of protein database search programs, Nucleic Acids Res., 25, 3389, 10.1093/nar/25.17.3389 · DOI · Paper page
- Balint, 1996, Increased rate of transcription contributes to elevated expression of the mutant p53 gene in Burkitt's lymphoma cells, Cancer Res., 56, 1648
- Belyi, 2010, The origins and evolution of the p53 family of genes, Cold Spring Harb. Perspect. Biol., 2, a001198, 10.1101/cshperspect.a001198 · DOI · Paper page
- Bergamaschi, 2003, iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human, Nat. Genet., 33, 162, 10.1038/ng1070 · DOI · Paper page
- Brandt, 2009, Conservation of DNA-binding specificity and oligomerisation properties within the p53 family, BMC Genomics, 10, 628, 10.1186/1471-2164-10-628 · DOI · Paper page
- Cahilly-Snyder, 1987, Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line, Somat. Cell Mol. Genet., 13, 235, 10.1007/BF01535205 · DOI · Paper page
- Calabro, 2002, The human MDM2 oncoprotein increases the transcriptional activity and the protein level of the p53 homolog p63, J. Biol. Chem., 277, 2674, 10.1074/jbc.M107173200 · DOI
- Derry, 2001, Caenorhabditis elegans p53: role in apoptosis, meiosis, and stress resistance, Science, 294, 591, 10.1126/science.1065486 · DOI · Paper page
- Eitel, 2011, New insights into placozoan sexual reproduction and development, PLoS One, 6, e19639, 10.1371/journal.pone.0019639 · DOI
- el-Deiry, 1993, WAF1, a potential mediator of p53 tumor suppression, Cell, 75, 817, 10.1016/0092-8674(93)90500-P · DOI · Paper page
- Fakharzadeh, 1991, Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line, EMBO J., 10, 1565, 10.1002/j.1460-2075.1991.tb07676.x · DOI · Paper page
- Fang, 2000, MDM2 is a RING finger-dependent ubiquitin protein ligase for itself and p53, J. Biol. Chem., 275, 8945, 10.1074/jbc.275.12.8945 · DOI · Paper page
- Flicek, 2011, Ensembl 2011, Nucleic Acids Res., 39, D800, 10.1093/nar/gkq1064 · DOI · Paper page
- Glazko, 2003, Estimation of divergence times for major lineages of primate species, Mol. Biol. Evol., 20, 424, 10.1093/molbev/msg050 · DOI · Paper page
- Haupt, 1997, MDM2 promotes the rapid degradation of p53, Nature, 387, 296, 10.1038/387296a0 · DOI · Paper page
- Hock, 2010, Regulation of the p53 pathway by ubiquitin and related proteins, Int. J. Biochem. Cell Biol., 42, 1618, 10.1016/j.biocel.2010.06.011 · DOI
- Hubbard, 2009, Ensembl 2009, Nucleic Acids Res., 37, D690, 10.1093/nar/gkn828 · DOI · Paper page
- Hunter, 2009, InterPro: the integrative protein signature database, Nucleic Acids Res., 37, D211, 10.1093/nar/gkn785 · DOI · Paper page
- Jin, 2000, Identification and characterization of a p53 homologue in Drosophila melanogaster, Proc. Natl. Acad. Sci. U.S.A., 97, 7301, 10.1073/pnas.97.13.7301 · DOI · Paper page
- Kadakia, 2001, Regulation of p63 function by MDM2 and MdmX, DNA Cell Biol., 20, 321, 10.1089/10445490152122433 · DOI
- Kallen, 2009, Crystal structures of human MdmX (HdmX) in complex with p53 peptide analogues reveal surprising conformational changes, J. Biol. Chem., 284, 8812, 10.1074/jbc.M809096200 · DOI
- Kojima, 2001, Analysis of molecular interactions of the p53-family p51(p63) gene products in a yeast two-hybrid system: homotypic and heterotypic interactions and association with p53-regulatory factors, Biochem. Biophys. Res. Commun., 281, 1170, 10.1006/bbrc.2001.4486 · DOI
- Kubbutat, 1997, Regulation of p53 stability by MDM2, Nature, 387, 299, 10.1038/387299a0 · DOI · Paper page
- Lane, 2010, MDM2 and p53 are highly conserved from placozoans to man, Cell Cycle, 9, 540, 10.4161/cc.9.3.10516 · DOI
- Lane, 2010, The MDM2 and p53 genes are conserved in the Arachnids, Cell Cycle, 9, 748, 10.4161/cc.9.4.10616 · DOI
- Larkin, 2007, Clustal W and Clustal X version 2.0, Bioinformatics, 23, 2947, 10.1093/bioinformatics/btm404 · DOI · Paper page
- Laurie, 2006, Inactivation of the p53 pathway in retinoblastoma, Nature, 444, 61, 10.1038/nature05194 · DOI · Paper page
- Liang, 2010, HDM4 is overexpressed in mantle cell lymphoma and its inhibition induces p21 expression and apoptosis, Mod. Pathol., 23, 381, 10.1038/modpathol.2009.170 · DOI
- Little, 2001, Hdmx and MDM2 can repress transcription activation by p53 but not by p63, Oncogene, 20, 4576, 10.1038/sj.onc.1204615 · DOI
- Margoliash, 1963, Primary structure and evolution of Cytochrome C, Proc. Natl. Acad. Sci. U.S.A., 50, 672, 10.1073/pnas.50.4.672 · DOI · Paper page
- Mavinahalli, 2010, Differences in the transactivation domains of p53 family members: a computational study, BMC Genomics, 11, S5, 10.1186/1471-2164-11-S1-S5 · DOI
- Miller, 2005, Animal evolution: the enigmatic phylum placozoa revisited, Curr. Biol., 15, R26, 10.1016/j.cub.2004.12.016 · DOI
- Miller, 2007, 28-way vertebrate alignment and conservation track in the UCSC Genome Browser, Genome Res., 17, 1797, 10.1101/gr.6761107 · DOI · Paper page
- Momand, 1992, The MDM-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation, Cell, 69, 1237, 10.1016/0092-8674(92)90644-R · DOI · Paper page
- Momand, 1998, The MDM2 gene amplification database, Nucleic Acids Res., 26, 3453, 10.1093/nar/26.15.3453 · DOI · Paper page
- Murphy, 2007, Using genomic data to unravel the root of the placental mammal phylogeny, Genome Res., 17, 413, 10.1101/gr.5918807 · DOI · Paper page
- Muttray, 2010, An invertebrate mdm homolog interacts with p53 and is differentially expressed together with p53 and ras in neoplastic Mytilus trossulus haemocytes, Comp. Biochem. Physiol. B Biochem. Mol. Biol., 156, 298, 10.1016/j.cbpb.2010.04.008 · DOI
- Nedelcu, 2007, Early diversification and complex evolutionary history of the p53 tumor suppressor gene family, Dev. Genes Evol., 217, 801, 10.1007/s00427-007-0185-9 · DOI
- Needleman, 1970, A general method applicable to the search for similarities in amino acid sequence of two proteins, J. Mol. Biol., 48, 443, 10.1016/0022-2836(70)90057-4 · DOI · Paper page
- Pazos, 2008, Protein co-evolution, co-adaptation and interactions, EMBO J., 27, 2648, 10.1038/emboj.2008.189 · DOI · Paper page
- Popowicz, 2007, Molecular basis for the inhibition of p53 by Mdmx, Cell Cycle, 6, 2386, 10.4161/cc.6.19.4740 · DOI
- Prasad, 2008, Confirming the phylogeny of mammals by use of large comparative sequence data sets, Mol. Biol. Evol., 25, 1795, 10.1093/molbev/msn104 · DOI · Paper page
- Putnam, 2008, The amphioxus genome and the evolution of the chordate karyotype, Nature, 453, 1064, 10.1038/nature06967 · DOI · Paper page
- Rice, 2000, EMBOSS: the European Molecular Biology Open Software Suite, Trends Genet., 16, 276, 10.1016/S0168-9525(00)02024-2 · DOI · Paper page
- Rutkowski, 2010, Phylogeny and function of the invertebrate p53 superfamily, Cold Spring Harb. Perspect. Biol., 2, a001131, 10.1101/cshperspect.a001131 · DOI
- Singh, 2007, Hetero-oligomerization with MdmX rescues the ubiquitin/Nedd8 ligase activity of RING finger mutants of MDM2, J. Biol. Chem., 282, 10901, 10.1074/jbc.M610879200 · DOI
- Srivastava, 2008, The Trichoplax genome and the nature of placozoans, Nature, 454, 955, 10.1038/nature07191 · DOI · Paper page
- Tanimura, 1999, MDM2 interacts with MDMX through their RING finger domains, FEBS Lett., 447, 5, 10.1016/S0014-5793(99)00254-9 · DOI · Paper page
- Uldrijan, 2007, An essential function of the extreme C-terminus of MDM2 can be provided by MDMX, EMBO J., 26, 102, 10.1038/sj.emboj.7601469 · DOI · Paper page
- Weber, 1999, Nucleolar Arf sequesters MDM2 and activates p53, Nat. Cell Biol., 1, 20, 10.1038/8991 · DOI · Paper page
- Yu, 2006, Solution structure of the C4 zinc finger domain of HDM2, Protein Sci., 15, 384, 10.1110/ps.051927306 · DOI
- Zdzalik, 2010, Interaction of regulators MDM2 and Mdmx with transcription factors p53, p63 and p73, Cell Cycle, 9, 4584, 10.4161/cc.9.22.13871 · DOI
Cited by
The p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches
Joerger, A. C., & Fersht, A. R. (2016) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060815-014710 · Cited by 661
Cancer across the tree of life: cooperation and cheating in multicellularity
Aktipis, C. A., Boddy, A. M., Jansen, G., Hibner, U., Hochberg, M. E., Maley, C. C., & Wilkinson, G. S. (2015) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2014.0219 · Cited by 466
Pathological Unfoldomics of Uncontrolled Chaos: Intrinsically Disordered Proteins and Human Diseases
Uversky, V. N., Davé, V., Iakoucheva, L. M., Malaney, P., Metallo, S. J., Pathak, R. R., & Joerger, A. C. (2014) · Chemical Reviews · doi:10.1021/cr400713r · Cited by 288
The role of ubiquitin modification in the regulation of p53
Hock, A. K., & Vousden, K. H. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.05.022 · Cited by 168
Zhang, Q., Balourdas, D.-I., Baron, B., Senitzki, A., Haran, T. E., Wiman, K. G., Soussi, T., & Joerger, A. C. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-04653-8 · Cited by 14
Metadata
- Authors
- Momand, J., Villegas, A., & Belyi, V. A.
- Venue
- Gene
- Publisher
- Elsevier BV
- Published
- 2011-10
- Volume
- 486
- Issue
- 1-2
- Pages
- 23-30
- ISSN
- 0378-1119
- Cited by
- 45
- References
- 16
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.